Clik here to view.
Cardeas Pharma Receives $1,001,523 New Financing
VentureDeal Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=35b90a87-9f57-4996-a1dc-8edf252a9482&Preview=1 Date 2/22/2011 Company Name Cardeas...
View ArticleClik here to view.
Montgomery Startup Gets $1M
Luke Timmerman Seattle-based Cardeas Pharma, a startup led by prominent biotech entrepreneur A. Bruce Montgomery, has raised its first $1 million, according to a regulatory filing. The company only...
View ArticleClik here to view.
Doxo, Kashless, Physiosonic led WA’s Equity Financing Deals in February
Curt Woodward Doxo’s bid to wipe out paper business correspondence attracted a $10 million round of venture financing last month, outpacing several others as the biggest single venture deal in...
View ArticleClik here to view.
Cardeas Pharma Obtains $5,000,000 New Funding Round
VentureDeal Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8e14fea4-bd41-4899-be4c-786be0d56406&Preview=1 Date 12/20/2011 Company Name Cardeas...
View ArticleClik here to view.
Bruce Montgomery’s New Startup, Cardeas Pharma, Raises $5M
Luke Timmerman Bruce Montgomery, the prominent Seattle biotech entrepreneur, has raised $5 million for his latest startup, Xconomy has learned. Cardeas Pharma has pulled in $5 million in equity...
View ArticleClik here to view.
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups
Luke Timmerman This was a great year for Seattle biotech if you measure success through sheer number of acquisitions. But if you prefer to measure the health of an innovation community by the number...
View ArticleClik here to view.
Reinventing Biotech’s Business Model: The Photo Gallery
Luke Timmerman Science is a risky business, and when money is tight, the margin for error gets narrower for those who dare to build biotech companies. Part of what that means is the CEO, or the head...
View ArticleClik here to view.
Cardeas Gears Up for Clinic, With Drug Combo for Hospital Infections
Luke Timmerman Once while reporting on a medical meeting for new antibiotics, I met a physician/researcher who said “stay in the hospital long enough, and something bad will happen to you.” Now the...
View ArticleClik here to view.
Avalon Ventures, Coming Off Zynga Investment, Raising 10th Fund
Bruce V. Bigelow Venture investing in the life sciences has been declining over the past year or so, along with a contraction in the number of VC firms that are actively investing. Yet San Diego’s...
View ArticleClik here to view.
Cardeas Pharma Obtains $2,991,213 New Funding Round
VentureDeal Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=24460c0a-a426-4af5-9e46-09d2bfc95448&Preview=1 Date 9/27/2012 Company Name Cardeas...
View ArticleClik here to view.
Cardeas Pharma Snags $34M For Antibiotic Against Hospital Infections
Luke Timmerman Seattle-based Cardeas Pharma just raised a lot more cash to fight a big problem that hospitals wrestle with every day, and which they’d rather not say much about publicly. Cardeas, the...
View ArticleClik here to view.
Cardeas Pharma Secures $34,000,000 Series B Funding Round
VentureDeal Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a0230868-49b2-44cb-a0e1-564866a064c0&Preview=1 Date 5/23/2013 Company Name Cardeas...
View Article